The -174 G/C polymorphism of the interleukin-6 gene promoter is associated with peripheral artery occlusive disease

European Journal of Vascular and Endovascular Surgery

Volumn 24, Issue 3, 2002, Pages 264-268

  Flex, A ^a   Gaetani, E ^a   Pola, R ^a   Santoliquido, A ^a   Aloi, F ^a   Papaleo, P ^a   Dal Lago, A ^a   Pola, E ^a   Serricchio, M ^a   Tondi, P ^a   Pola, P ^a  

^a FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

Author keywords

Gene polymorphism; Interleukin 6; Peripheral artery occlusive disease

Indexed keywords

INTERLEUKIN 6; RESTRICTION ENDONUCLEASE;

AGED; ALLELE; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY DISEASE; CASE CONTROL STUDY; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DNA POLYMORPHISM; FEMALE; GENETIC TRANSCRIPTION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION MAPPING; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; PERIPHERAL VASCULAR DISEASE; RISK;

AGED; AGED, 80 AND OVER; ARTERIAL OCCLUSIVE DISEASES; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN-6; MALE; ODDS RATIO; PERIPHERAL VASCULAR DISEASES; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS);

EID: 19044377139     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1053/ejvs.2002.1711     Document Type: Article

References (29)

1. MILEI J, PARODI JC, FERNANDEZ ALONSO G et al. Carotid Atherosclerosis. Immunocytochemical analysis of the vascular and cellular composition in endarterectomies. Cardiologia 1996; 41: 535-542.
2. VAN DER WAL AC, BECKER AE, VAN DER LOOS CM, DAS PK. Site of intimal rupture or erosion of thromboses coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994; 89: 36-44.
3. BUJA LM, WILLERSON JT. Role of inflammation in coronary plaque distruption. Circulation 1994; 89: 503-505.
4. ROSS R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999; 340: 115-126.
5. HEINRICH PC, CASTELL JV, ANDUS T. Interleukin-6 and the acute phase response. Biochem J 1990; 265: 621-636.
6. ROMANO M, SIRONI M, TONIATTI C et al. A. Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity 1997; 6: 315-325.
7. DALMON J, LAURENT M, COURTOIS G. The human beta fibrinogen promoter contains a hepatocyte nuclear factor 1-dependent interleukin-6-responsive element. Mol Cell Biol 1993; 13: 1183-1193.
8. BIASUCCI LM, VITELLI A, LIUZZO G et al. Elevated levels of interleukin-6 in unstable angina. Circulation 1996; 94: 874-847.
9. GRAU AJ, AULMANN M, LICHY C et al. Increased cytokine release by leucocytes in survivors of stroke at young age. Eur J Clin Invest 2001; 31: 999-1006
10. RIDKER PM, RIFAI N, STAMPFER MJ, HENNEKENS CH. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000; 101: 1767-1772.
11. FISHMAN D, FAULDS G, JEFFERY R. The effect of novel polymorphism in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic onset juvenile chronic arthritis. J Clin Invest 1998; 102: 1369-1376.
12. TERRY CF, LOUKACI V, GREEN FR. Cooperative influence of genetic polymorphisms on interleukin-6 transcriptional regulation. J Biol Chem 2000; 275: 18138-18144.
13. JONES KG, BRULL DJ, BROWN LC, SIAN M et al. Interleukin-6 (IL-6) and the prognosis of abdominal aortic aneurysms. Circulation 2001; 103: 2260-2265.
14. HUMPHRIES SE, LUONG LA, OGG MS, HAWE E, MILLER GJ. The interleukin-6 -174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men. Eur Heart J 2001; 22: 2243-2252
15. RUTHERFORD RB, FLANIGAN DP, GUPTA SK, AND THE AD HOC COMMITTEE ON REPORTING STANDARDS SVS/ISCVS. Suggested standards for reports dealing with lower extremity ischaemia. J Vasc Surg 1986; 4: 80-94.
16. Ross R. The pathogenesis of atherosclerosis: a prospective for the 1990s. Nature 1993; 362: 801-809.
17. LIBBY P, Ross R. Cytokines and growth regulatory molecules. In: Fuster V, Ross R, Topol EJ, eds. Atherosclerosis and Coronary Artery Disease. Vol. 1. Philadelphia: Lippincott-Raven, 1996: 585-594.
18. FALK E, SHAN PK, FUSTER V. Pathogenesis of plaque distruption. In: Fuster V, Ross R, Topol EJ, eds. Atherosclerosis and Coronary Artery Disease. Vol. 2. Philadelphia:lippincott.Raven 1996: 492-510.
19. RAURAMAA R, VAISANEN SB, LUONG LA et al. Stromelysin-1 and interleukin-6 gene promoter polymorphisms are determinants of asymptomatic carotid artery atherosclerosis. Arterioscler Thromb Vasc Biol 2000; 20: 2657-2662.
20. RUS HG, VLAICU R, NICULESCU F. Interleukin-6 and interleukin-8 protein and gene expression in human arterial atherosclerotic wall. Atherosclerosis 1996; 127: 263-271.
21. SUKOVICH DA, KAUSER K, SHIRLEY FD et al. Expression of interleukin-6 in atherosclerotic lesions of male ApoE-knockout mice: inhibition by 17β-estradiol. Arterioscler Thromb Vasc Biol 1998; 18: 1498-1505.
22. MIYAO Y, YASUE H, OGAWA H et al. Elevated plasma interleukin-6 levels in patients with acute myocardial infarction. Am Heart J 1993; 126: 1299-1304.
23. GUILLEN I, BLANES M, GOMEZ-LECHON MJ, CASTELL JV. Cytokine signalling during myocardial infarction: sequential appearance of IL-1 beta and IL-6. Am J Physiol 1995; 269: R229-R235.
24. BIASUCCI LM, LIUZZO G, FANTUZZI G et al. Increasing levels of interleukin (IL)-IRa and IL-6 during the first 2 days of hospitalization in unstable angina are associated with increased risk of in-hospital coronary events. Circulation 1999; 99: 2079-2084.
25. VAN SNICK J. Interleukin-6: an overview. Ann Rev Immunol 1990; 8: 253-278.
26. PAPANICOLAU DA, WILDER RL, MANOLAGAS SC, CHROUSOS GP. The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med 1998; 128: 127-137.
27. MARIAN AJ. On genetics, inflammation, and abdominal aortic aneurysm. Circulation 2001; 103: 2222-2224.
28. IKONOMIDIS I, ANDREOTTI F, ECONOMOU E et al. Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin. Circulation 1999; 100: 793-798.
29. BAGLI M, PAPASSOTIROPOULOS A, KNAPP M et al. Association between an interleukin-6 promoter and 3′ flanking region haplotype and reduced Alzheimer's disease risk in a German population. Neurosci Lett 2000; 283: 109-112.